Analysis of Nootropics Using GC-MS(/MS) - Part 2
By performing mass separation in two stages, GC-MS/MS analysis is able to separate and detect contaminants in medicinal toxicants and biological samples with high sensitivity. Consequently, it can simplify the process of determining whether or not biological samples contain medicinal toxicants and can significantly shorten the time required for data analysis. However, analysis in the MRM mode requires optimizing MRM transitions and collision energies (CEs). Due to the time and trouble required for that optimization process, users have been asking for a pre-optimized database.
Smart Forensic Database Ver. 2 is registered with information necessary for MRM analysis. In this new version, the number of registered medicinal toxicants was increased from 201 components to 486 components. This comprehensive enhancement in medicinal toxicant information, such as for drugs of abuse, psychotropic drugs, general pharmaceuticals, and pesticides, significantly increases the number of medicinal toxicants that can be monitored with a single measurement.
This Application Data Sheet describes an example of using Smart Forensic Database Ver. 2 to analyze nootropics in blood plasma.
- Content Type:
- Application
- Document Number:
- LAAN-J-MS-E142
- Product Type:
- Gas Chromatograph-Mass Spectrometry, Mass Spectrometry
- Keywords:
- Nootropics, Smart Forensic Database, Clinical research, Forensics, Pharmaceutical, Life Science, Forensics, Toxicology, Drug test, GCMS-TQ8040
- Language:
- English
- File Name:
- jpo218007.pdf
- File Size:
- 87kb